ELOXX PHARMACEUTICALS, INC. Investing Cash Flow
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Investing Cash Flow of $1.00 thousand for the 12-month period ending 2025-12-31, per its S-1 filed 2026-09-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $51.00K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $233.00K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-06-30 was $14.00K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2023-03-31 was $11.00K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$66.00K, a 103.21% decline from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2021 was $2.06M, a 93.92% decline from fiscal 2020.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2020 was $33.79M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2019 was -$33.52M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed | Net Cash Provided by (Used in) Investing Activities 159 month | Net Cash Provided by (Used in) Investing Activities 162 month | Net Cash Provided by (Used in) Investing Activities 165 month | Net Cash Provided by (Used in) Investing Activities 168 month | Net Cash Provided by (Used in) Investing Activities 171 month | Net Cash Provided by (Used in) Investing Activities 174 month | Net Cash Provided by (Used in) Investing Activities 177 month | Net Cash Provided by (Used in) Investing Activities 180 month | Net Cash Provided by (Used in) Investing Activities 183 month | Net Cash Provided by (Used in) Investing Activities 186 month | Net Cash Provided by (Used in) Investing Activities 189 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.00K S-1 · filed 2026-09-11 | ||||||||||||||||
| 2024-12-31 | $38.00K S-1 · filed 2026-09-11 | ||||||||||||||||
| 2023-12-31 | $51.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-11 | $284.00K derived: sum of 2 quarters · filed 2026-09-11 | $298.00K derived: sum of 3 quarters · filed 2026-09-11 | $309.00K S-1 · filed 2026-09-11 | |||||||||||||
| 2023-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $247.00K derived: sum of 2 quarters · filed 2023-11-13 | $258.00K 10-Q · filed 2023-11-13 | $258.00K derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $25.00K 10-Q · filed 2023-08-11 | $25.00K derived: sum of 3 quarters · filed 2023-08-11 | -$23.00K derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2023-03-31 | $11.00K 10-Q · filed 2023-05-12 | $11.00K derived: sum of 2 quarters · filed 2023-05-12 | -$37.00K derived: sum of 3 quarters · filed 2023-11-13 | -$44.00K derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$48.00K derived: sum of 2 quarters · filed 2023-11-13 | -$55.00K derived: sum of 3 quarters · filed 2023-11-13 | -$66.00K 10-K · filed 2023-03-31 | |||||||||||||
| 2022-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$55.00K derived: sum of 2 quarters · filed 2023-11-13 | -$66.00K 10-Q · filed 2023-11-13 | -$86.00K derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$18.00K 10-Q · filed 2023-08-11 | -$38.00K derived: sum of 3 quarters · filed 2023-08-11 | -$107.00K derived: sum of 4 quarters · filed 2023-08-11 | |||||||||||||
| 2022-03-31 | -$11.00K 10-Q · filed 2023-05-12 | -$31.00K derived: sum of 2 quarters · filed 2023-05-12 | -$100.00K derived: sum of 3 quarters · filed 2023-05-12 | ||||||||||||||
| 2021-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$89.00K derived: sum of 2 quarters · filed 2023-03-31 | $2.06M 10-K · filed 2023-03-31 | ||||||||||||||
| 2021-09-30 | -$69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.08M 10-Q · filed 2022-11-10 | |||||||||||||||
| 2021-06-30 | $2.15M 10-Q · filed 2022-08-12 | ||||||||||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $6.75M derived: sum of 2 quarters · filed 2022-03-30 | $18.00M derived: sum of 3 quarters · filed 2022-03-30 | $33.79M 10-K · filed 2022-03-30 | |||||||||||||
| 2020-09-30 | $6.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $18.00M derived: sum of 2 quarters · filed 2021-11-08 | $33.79M 10-Q · filed 2021-11-08 | $42.87M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||||
| 2020-06-30 | $11.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $27.04M 10-Q · filed 2021-08-16 | $36.12M derived: sum of 3 quarters · filed 2022-03-30 | $20.38M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||||
| 2020-03-31 | $15.79M 10-Q · filed 2021-05-07 | $24.87M derived: sum of 2 quarters · filed 2022-03-30 | $9.13M derived: sum of 3 quarters · filed 2022-03-30 | -$8.79M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||||
| 2019-12-31 | $9.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$6.66M derived: sum of 2 quarters · filed 2022-03-30 | -$24.58M derived: sum of 3 quarters · filed 2022-03-30 | -$33.52M 10-K · filed 2022-03-30 | |||||||||||||
| 2019-09-30 | -$15.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$33.66M derived: sum of 2 quarters · filed 2020-11-06 | -$42.60M 10-Q · filed 2020-11-06 | -$42.78M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||||
| 2019-06-30 | -$17.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$26.86M 10-Q · filed 2020-08-07 | -$27.04M derived: sum of 3 quarters · filed 2021-03-12 | -$27.08M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||||
| 2019-03-31 | -$8.94M 10-Q · filed 2020-05-08 | -$19.00K 10-Q · filed 2019-05-09 | -$9.12M derived: sum of 2 quarters · filed 2021-03-12 | -$9.16M derived: sum of 3 quarters · filed 2021-03-12 | -$9.20M derived: sum of 4 quarters · filed 2021-03-12 | ||||||||||||
| 2018-12-31 | -$179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$216.00K derived: sum of 2 quarters · filed 2021-03-12 | -$260.00K derived: sum of 3 quarters · filed 2021-03-12 | -$317.00K 10-K · filed 2021-03-12 | |||||||||||||
| 2018-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$81.00K derived: sum of 2 quarters · filed 2019-11-06 | -$138.00K 10-Q · filed 2019-11-06 | -$97.00K derived: sum of 4 quarters · filed 2020-03-06 | |||||||||||||
| 2018-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$101.00K 10-Q · filed 2019-08-07 | -$60.00K derived: sum of 3 quarters · filed 2020-03-06 | -$60.00K derived: sum of 4 quarters · filed 2020-03-06 | |||||||||||||
| 2018-03-31 | -$57.00K 10-Q · filed 2019-05-09 | -$16.00K derived: sum of 2 quarters · filed 2020-03-06 | -$16.00K derived: sum of 3 quarters · filed 2020-03-06 | -$16.00K derived: sum of 4 quarters · filed 2020-03-06 | |||||||||||||
| 2017-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $41.00K derived: sum of 2 quarters · filed 2020-03-06 | $41.00K derived: sum of 3 quarters · filed 2020-03-06 | -$114.00K 10-K · filed 2020-03-06 | -$178.00K 10-K · filed 2018-03-16 | ||||||||||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-08-10 | -$155.00K 10-Q · filed 2018-11-08 | ||||||||||||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$96.00K 10-Q · filed 2018-08-10 | |||||||||||||||
| 2017-03-31 | -$96.00K 10-Q · filed 2018-05-10 | ||||||||||||||||
| 2016-12-31 | -$36.00K 10-K · filed 2019-03-14 | -$50.00K 10-K · filed 2018-03-16 | |||||||||||||||
| 2016-09-30 | $50.00K 10-Q · filed 2017-11-14 | ||||||||||||||||
| 2015-12-31 | $1.49M 10-K · filed 2018-03-16 | ||||||||||||||||
| 2014-09-30 | -$334.80K 10-Q · filed 2014-11-14 | $721.77K derived: sum of 2 quarters · filed 2014-11-14 | $565.36K derived: sum of 3 quarters · filed 2014-11-14 | $455.07K derived: sum of 4 quarters · filed 2014-11-14 | |||||||||||||
| 2014-06-30 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $900.17K derived: sum of 2 quarters · filed 2014-09-29 | $789.88K derived: sum of 3 quarters · filed 2014-09-29 | $646.94K 10-K · filed 2014-09-29 | |||||||||||||
| 2014-03-31 | -$156.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | -$266.69K derived: sum of 2 quarters · filed 2014-05-09 | -$409.64K 10-Q · filed 2014-05-09 | -$543.73K derived: sum of 4 quarters · filed 2014-11-14 | -$7.35M 10-Q · filed 2014-05-09 | ||||||||||||
| 2013-12-31 | -$110.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | -$253.23K 10-Q · filed 2014-02-14 | -$387.33K derived: sum of 3 quarters · filed 2014-11-14 | -$528.76K derived: sum of 4 quarters · filed 2014-11-14 | -$7.19M 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | -$142.94K 10-Q · filed 2014-11-14 | -$277.04K derived: sum of 2 quarters · filed 2014-11-14 | -$418.47K derived: sum of 3 quarters · filed 2014-11-14 | -$524.99K derived: sum of 4 quarters · filed 2014-11-14 | -$7.08M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | -$134.10K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$275.53K derived: sum of 2 quarters · filed 2014-09-29 | -$382.04K derived: sum of 3 quarters · filed 2014-09-29 | -$529.04K 10-K · filed 2014-09-29 | -$6.94M 10-K · filed 2013-09-11 | ||||||||||||
| 2013-03-31 | -$141.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | -$247.95K derived: sum of 2 quarters · filed 2014-05-09 | -$394.94K 10-Q · filed 2014-05-09 | -$501.77K derived: sum of 4 quarters · filed 2014-09-29 | -$6.80M 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | -$106.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | -$253.51K 10-Q · filed 2014-02-14 | -$360.33K derived: sum of 3 quarters · filed 2014-09-29 | -$471.62K derived: sum of 4 quarters · filed 2014-09-29 | -$6.66M 10-Q · filed 2013-02-14 | ||||||||||||
| 2012-09-30 | -$147.00K 10-Q · filed 2013-11-14 | -$253.82K derived: sum of 2 quarters · filed 2014-09-29 | -$365.10K derived: sum of 3 quarters · filed 2014-09-29 | -$468.65K derived: sum of 4 quarters · filed 2014-09-29 | -$6.56M 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | -$106.82K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$218.11K derived: sum of 2 quarters · filed 2014-09-29 | -$321.66K derived: sum of 3 quarters · filed 2014-09-29 | -$450.50K 10-K · filed 2014-09-29 | -$6.41M 10-K/A · filed 2012-10-26 | ||||||||||||
| 2012-03-31 | -$111.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | -$214.84K derived: sum of 2 quarters · filed 2013-05-15 | -$343.68K 10-Q · filed 2013-05-15 | -$593.13K derived: sum of 4 quarters · filed 2013-09-11 | -$6.30M 10-Q · filed 2012-05-14 | ||||||||||||
| 2011-12-31 | -$103.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | -$232.39K 10-Q · filed 2013-02-14 | -$481.85K derived: sum of 3 quarters · filed 2013-09-11 | -$658.51K derived: sum of 4 quarters · filed 2013-09-11 | -$6.19M 10-Q · filed 2012-02-14 | ||||||||||||
| 2011-09-30 | -$128.84K 10-Q · filed 2012-11-14 | -$378.30K derived: sum of 2 quarters · filed 2013-09-11 | -$554.96K derived: sum of 3 quarters · filed 2013-09-11 | -$685.58K derived: sum of 4 quarters · filed 2013-09-11 | -$6.09M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | -$249.46K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | -$426.12K derived: sum of 2 quarters · filed 2013-09-11 | -$556.74K derived: sum of 3 quarters · filed 2013-09-11 | -$686.42K 10-K · filed 2013-09-11 | |||||||||||||
| 2011-03-31 | -$176.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | -$307.29K derived: sum of 2 quarters · filed 2012-05-14 | -$436.97K 10-Q · filed 2012-05-14 | ||||||||||||||
| 2010-12-31 | -$130.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | -$260.30K 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-09-30 | -$129.68K 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | $240.97K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |